Egalet (EGLT) : 4-month performance

• Egalet Corporation filed for Chapter 11 bankruptcy in October 2018, leading to the cancellation of its existing common stock and the extinguishment of shareholder interests. The company reorganized to emerge from bankruptcy in late 2019, with bondholders and Iroko Pharmaceuticals taking ownership. Subsequently, Egalet changed its name to Zyla Life Sciences. 
• Zyla Life Sciences merged with Assertio Therapeutics in May 2020, creating a new entity called Assertio Holdings, Inc. (Nasdaq: ASRT). 
• To learn more about Assertio, visit www.assertiotx.com.